World - Amine-Function Compounds - Market Analysis, Forecast, Size, Trends and Insights
Product coverage: acyclic monoamines and polyamines and their derivatives and salts thereof, aromatic monoamines and polyamines and their derivatives and salts thereof and other amine-function compounds.
This report provides an in-depth analysis of the global amine-function compound market. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2025.
Worldwide - the report contains statistical data for 200 countries and includes detailed profiles of the 50 largest consuming countries (United States, China, Japan, Germany, United Kingdom, France, Brazil, Italy, Russian Federation, India, Canada, Australia, Republic of Korea, Spain, Mexico, Indonesia, Netherlands, Turkey, Saudi Arabia, Switzerland, Sweden, Nigeria, Poland, Belgium, Argentina, Norway, Austria, Thailand, United Arab Emirates, Colombia, Denmark, South Africa, Malaysia, Israel, Singapore, Egypt, Philippines, Finland, Chile, Ireland, Pakistan, Greece, Portugal, Kazakhstan, Algeria, Czech Republic, Qatar, Peru, Romania, Vietnam) + the largest producing countries.
Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd., BASF SE, Johnson & Johnson, Cilag AG, Hainan Nuode Medicine Co., Ltd., PETRONIKA, PT, Kunming Dongfang Pharmaceutical Co., Ltd., Syntex Pharm AG, F. Hoffmann-La Roche AG, Pfizer Inc., Biopharm AG, Roche Chemische Unternehmungen AG, Novartis Corporation, Novartis Pharmaceuticals Corporation, Novartis Pharma Stein AG, Novartis Pharma AG, GSK Consumer Healthcare S.A., Novartis Pharma Schweizerhalle AG, Hebei Huiyuan Coking & Gas Making Group Co., Ltd., Bayer AG, GLAXOSMITHKLINE PLC, Merck & Co., Inc., SAUDI BASIC INDUSTRIES CORPORATION (SABIC), Abbvie Inc., Abbott Laboratories, Gilead Sciences, Inc., Eli Lilly Vostok SA, ALGORITHM SAL, Eli Lilly and Company, ASTRAZENECA PLC, TEVA PHARMACEUTICAL INDUSTRIES LIMITED, Bristol-Myers Squibb Company, MERCK KG auf Aktien, Novo Nordisk A/S, TAKEDA PHARMACEUTICAL COMPANY LIMITED, BASF Corporation, INDOCO REMEDIES LIMITED, CJ CheilJedang Corporation, Braskem S/A, PPG Switzerland GmbH, Umicore SA, SHIN-ETSU CHEMICAL CO., LTD., Celgene Corporation, Celgene Chemicals Sàrl, MITSUI CHEMICALS,INC., Janssen Pharmaceutica NV, Biogen Inc., ASTELLAS PHARMA INC., FORMOSA CHEMICALS & FIBRE CORP., Merck Sharp & Dohme International Services B.V.